IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Andera Partners

Q1 2026 Holdings

Filed 2026-05-11 | 7 holdings | $176.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Kestra MED Technologies LTD(KMTS)SHSG52441105$53.7M2,695,19230.4%
Evommune Inc(EVMN)COM SHS30054Y107$43.6M1,897,36224.7%
Mineralys Therapeutics Inc(MLYS)COM603170101$43.1M1,591,91724.4%
Agomab Therapeutics NV(AGMB)SPONSORED ADS00860C102$16.1M1,538,7029.1%
Inventiva SA(IVA)ADS46124U107$10.1M1,818,1815.7%
Abivax SA(ABVX)SPONSORED ADS00370M103$8.7M78,1254.9%
Nyxoah S A(NYXH)SHSB6S7WD106$1.5M522,0570.9%